相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Personalized Management of Pheochromocytoma and Paraganglioma
Svenja Noelting et al.
ENDOCRINE REVIEWS (2022)
Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting
Lester D. R. Thompson et al.
HUMAN PATHOLOGY (2021)
Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
Toni K. Choueiri et al.
NATURE MEDICINE (2021)
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma
Lauren Fishbein et al.
PANCREAS (2021)
Genetics of pheochromocytoma and paraganglioma
Heather Wachtel et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2021)
New approaches to predict the effect of co-occurring variants on protein characteristics
David Holcomb et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
A community challenge to evaluate RNA-seq, fusion detection, and isoform quantification methods for cancer discovery
Allison Creason et al.
CELL SYSTEMS (2021)
Recognizing hypoxia in phaeochromocytomas and paragangliomas
Patricia L. M. Dahia et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma
Alexandre Buffet et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
Jacques W. M. Lenders et al.
JOURNAL OF HYPERTENSION (2020)
Antiangiogenic therapies for pheochromocytoma and paraganglioma
Camilo Jimenez et al.
ENDOCRINE-RELATED CANCER (2020)
Functional Characterization of TMEM127 Variants Reveals Novel Insights into Its Membrane Topology and Trafficking
Shahida K. Flores et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas
Camilo Jimenez et al.
CANCERS (2020)
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Fassnacht et al.
ANNALS OF ONCOLOGY (2020)
MYC Regulation of D2HGDH and L2HGDH Influences the Epigenome and Epitranscriptome
ZhiJun Qiu et al.
CELL CHEMICAL BIOLOGY (2020)
Performance of 68Ga-DOTA-Conjugated Somatostatin Receptor-Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis
Sangwon Han et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Metastatic Phaeochromocytoma: Spinning Towards More Promising Treatment Options
Svenja Noelting et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2019)
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma
Susan Richter et al.
GENETICS IN MEDICINE (2019)
Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma
Alexandre Buffet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma
Laurene Ben Aim et al.
JOURNAL OF MEDICAL GENETICS (2019)
A Developmental Perspective on Paragangliar Tumorigenesis
Lavinia Vittoria Lotti et al.
CANCERS (2019)
Synonymous but Not Silent: A Synonymous VHL Variant in Exon 2 Confers Susceptibility to Familial Pheochromocytoma and von Hippel-Lindau Disease
Shahida K. Flores et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration
Alberto Cascon et al.
CANCERS (2019)
y Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches
Laura Gieldon et al.
CANCERS (2019)
Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of Origin
Karen Koopman et al.
CANCERS (2019)
Integrated genomic profiling expands clinical options for patients with cancer
Nike Beaubier et al.
NATURE BIOTECHNOLOGY (2019)
Pheochromocytoma and Paraganglioma
Hartmut P. H. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma
Sylvie Job et al.
CLINICAL CANCER RESEARCH (2019)
Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Daniel A. Pryma et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas
Laura Remacha et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy
Hartmut P. H. Neumann et al.
JAMA NETWORK OPEN (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease
Marion Lenglet et al.
BLOOD (2018)
Gain-of-function mutations in DNMT3A in patients with paraganglioma
Laura Remacha et al.
GENETICS IN MEDICINE (2018)
The TMEM127 human tumor suppressor is a component of the mTORC1 lysosomal nutrient-sensing complex
Yilun Deng et al.
HUMAN MOLECULAR GENETICS (2018)
EPAS1 Mutations and Paragangliomas in Cyanotic Congenital Heart Disease
Anand Vaidya et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Andre Kahles et al.
CANCER CELL (2018)
Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas
Rodrigo A. Toledo et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
Joakim Crona et al.
ENDOCRINE REVIEWS (2017)
New HIF2α inhibitors: potential implications as therapeutics for advanced pheochromocytomas and paragangliomas
Rodrigo Almeida Toledo
ENDOCRINE-RELATED CANCER (2017)
Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma
Grace Kong et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics
Maria Curras-Freixes et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma
David Taieb et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Lauren Fishbein et al.
CANCER CELL (2017)
Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas
Rodrigo A. Toledo et al.
CLINICAL CANCER RESEARCH (2016)
Rethinking pheochromocytomas and paragangliomas from a genomic perspective
L. J. Castro-Vega et al.
ONCOGENE (2016)
Pheochromocytoma and Paraganglioma Genetics, Diagnosis, and Treatment
Lauren Fishbein
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma
Aidan Flynn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma
Ingo Janssen et al.
CLINICAL CANCER RESEARCH (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Pheochromocytoma and Paraganglioma in Cyanotic Congenital Heart Disease
Alexander R. Opotowsky et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)
Thomas G. Papathomas et al.
MODERN PATHOLOGY (2015)
Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas
Luis Jaime Castro-Vega et al.
NATURE COMMUNICATIONS (2015)
Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
Lauren Fishbein et al.
NATURE COMMUNICATIONS (2015)
Paraganglioma and phaeochromocytoma: from genetics to personalized medicine
Judith Favier et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
Luis Jaime Castro-Vega et al.
HUMAN MOLECULAR GENETICS (2014)
The tumor susceptibility gene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal function
Y. Qin et al.
HUMAN MOLECULAR GENETICS (2014)
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
Jacques W. M. Lenders et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity
Patricia L. M. Dahia
NATURE REVIEWS CANCER (2014)
In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas
Rodrigo A. Toledo et al.
ENDOCRINE-RELATED CANCER (2013)
The Genetic Landscape of Pheochromocytomas and Paragangliomas: Somatic Mutations Take Center Stage
Patricia L. M. Dahia
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas Insights from the largest single-institutional experience
Montserrat Ayala-Ramirez et al.
CANCER (2012)
Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas
Jenny Welander et al.
HUMAN MOLECULAR GENETICS (2012)
Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators
Montserrat Ayala-Ramirez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Mutation of SDHB is a Cause of Hypoxia-Related High-Altitude Paraganglioma
Nidia Y. Cerecer-Gil et al.
CLINICAL CANCER RESEARCH (2010)
Spectrum and Prevalence of FP/TMEM127 Gene Mutations in Pheochromocytomas and Paragangliomas
Li Yao et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Germline mutations in TMEM127 confer susceptibility to pheochromocytoma
Yuejuan Qin et al.
NATURE GENETICS (2010)
Novel and Evolving Therapies in the Treatment of Malignant Phaeochromocytoma: Experience with the mTOR Inhibitor Everolimus (RAD001)
M. R. Druce et al.
HORMONE AND METABOLIC RESEARCH (2009)
Comparison of F-18-Fluoro-L-DOPA, F-18-Fluoro-Deoxyglucose, and F-18-Fluorodopamine PET and I-123-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma
Henri J. L. M. Timmers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Transcriptome sequencing to detect gene fusions in cancer
Christopher A. Maher et al.
NATURE (2009)
Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts
Joshua Z. Levin et al.
GENOME BIOLOGY (2009)
Genetic analysis of high altitude paragangliomas
Marion Jech et al.
ENDOCRINE PATHOLOGY (2006)
A HIF1α regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas
PLM Dahia et al.
PLOS GENETICS (2005)
Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect
K Astrom et al.
HUMAN GENETICS (2003)
The incidence of congenital heart disease
JIE Hoffman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast
LA Mucci et al.
JOURNAL OF INTERNAL MEDICINE (2001)
分享论文
